Aggressive periodontitis (AP) is a multifactorial, severe, and rapidly progressive form of periodontitis that primarily affects younger patients. It is characterized by a unique set of clinical and microbiological features that distinguish it from other forms of periodontal disease.

Key Characteristics

• Rapid Progression: AP is marked by a swift deterioration of periodontal tissues.
• Age Group: Primarily affects adolescents and young adults, but can occur at any age.
• Multifactorial Etiology: Involves a combination of microbiological, immunological, genetic, and environmental factors.

Other Findings

• Presence of Aggregatibacter actinomycetemcomitans (A.a.) in diseased sites.
• Abnormal host responses, including impaired phagocytosis and chemotaxis.
• Hyperresponsive macrophages leading to exaggerated inflammatory responses.
• The disease may exhibit self-arresting tendencies in some cases.

Classification

Aggressive periodontitis can be classified into two main types:

1. Localized Aggressive Periodontitis (LAP): Typically affects the permanent molars and incisors, often with localized attachment loss.
2. Generalized Aggressive Periodontitis (GAP): Involves more widespread periodontal tissue destruction.

Risk Factors

Microbiological Factors

• Aggregatibacter actinomycetemcomitans: A primary pathogen associated with LAP, producing a potent leukotoxin that kills neutrophils.
• Different strains of A.a. produce varying levels of leukotoxin, with highly toxic strains more prevalent in affected individuals.

Immunological Factors

• Human Leukocyte Antigens (HLAs): HLA-A9 and B-15 are candidate markers for aggressive periodontitis.
• Defective neutrophil function leads to impaired chemotaxis and phagocytosis.
• Hyper-responsive macrophage phenotype, characterized by elevated levels of PGE2 and IL-1β, may contribute to connective tissue breakdown and bone loss.

Genetic Factors

• Familial clustering of neutrophil abnormalities suggests a genetic predisposition.
• Genetic control of antibody responses to A.a., with variations in the ability to produce protective IgG2 antibodies.

Environmental Factors

• Smoking is a significant risk factor, with smokers experiencing more severe periodontal destruction compared to non-smokers.

Treatment Approaches

General Considerations

• Treatment strategies depend on the type and extent of periodontal destruction.
• GAP typically has a poorer prognosis compared to LAP, as it is less likely to enter spontaneous remission.

Conventional Periodontal Therapy

• Patient Education: Informing patients about the disease and its implications.
• Oral Hygiene Instructions: Reinforcing proper oral hygiene practices.
• Scaling and Root Planing: Removal of plaque and calculus to control local factors.

Surgical Resection Therapy

• Aimed at reducing or eliminating pocket depth.
• Contraindicated in cases of severe horizontal bone loss due to the risk of increased tooth mobility.

Regenerative Therapy

• Potential for regeneration is promising in AP cases.
• Techniques include open flap surgical debridement, root surface conditioning with tetracycline, and the use of allogenic bone grafts.
• Recent advances involve the use of enamel matrix proteins to promote cementum regeneration and new attachment.

Antimicrobial Therapy

• Often required as adjunctive treatment to eliminate A.a. from periodontal tissues.
• Tetracycline: Administered in various regimens to concentrate in periodontal tissues and inhibit A.a. growth.
• Combination Therapy: Metronidazole combined with amoxicillin has shown efficacy alongside periodontal therapy.
• Doxycycline: Used at a dose of 100 mg/day.
• Chlorhexidine (CHX): Irrigation and home rinsing to control bacterial load.

Host Modulation

• Involves the use of sub-antimicrobial dose doxycycline (SDD) to prevent periodontal attachment loss by modulating the activity of matrix metalloproteinases (MMPs), particularly collagenase and gelatinase.

Modified Gingival Index (MGI)

The Modified Gingival Index (MGI) is a clinical tool used to assess the severity of gingival inflammation. It provides a standardized method for evaluating the health of the gingival tissues, which is essential for diagnosing periodontal conditions and monitoring treatment outcomes. Understanding the scoring criteria of the MGI is crucial for dental professionals in their assessments.

Scoring Criteria for the Modified Gingival Index (MGI)

The MGI uses a scale from 0 to 4 to classify the degree of gingival inflammation. Each score corresponds to specific clinical findings:

1. Score 0: Absence of Inflammation

   • Description: No signs of inflammation are present in the gingival tissues.
   • Clinical Significance: Indicates healthy gingiva with no bleeding or other pathological changes.

2. Score 1: Mild Inflammation

   • Description:
     • Slight change in color (e.g., slight redness).
     • Little change in texture of any portion of the marginal or papillary gingival unit, but not affecting the entire unit.
   • Clinical Significance: Suggests early signs of gingival inflammation, which may require monitoring and preventive measures.

3. Score 2: Mild Inflammation (Widespread)

   • Description:
     • Similar criteria as Score 1, but involving the entire marginal or papillary gingival unit.
   • Clinical Significance: Indicates a more widespread mild inflammation that may necessitate intervention to prevent progression.

4. Score 3: Moderate Inflammation

   • Description:
     • Glazing of the gingiva.
     • Redness, edema, and/or hypertrophy of the marginal or papillary gingival unit.
   • Clinical Significance: Reflects a moderate level of inflammation that may require active treatment to reduce inflammation and restore gingival health.

5. Score 4: Severe Inflammation

   • Description:
     • Marked redness, edema, and/or hypertrophy of the marginal or papillary gingival unit.
     • Presence of spontaneous bleeding, congestion, or ulceration.
   • Clinical Significance: Indicates severe gingival disease that requires immediate intervention and may be associated with periodontal disease.

Clinical Application of the MGI

1. Assessment of Gingival Health:

   • The MGI provides a systematic approach to evaluate gingival health, allowing for consistent documentation of inflammation levels.

2. Monitoring Treatment Outcomes:

   • Regular use of the MGI can help track changes in gingival health over time, assessing the effectiveness of periodontal treatments and preventive measures.

3. Patient Education:

   • The MGI can be used to educate patients about their gingival health status, helping them understand the importance of oral hygiene and regular dental visits.

4. Research and Epidemiological Studies:

   • The MGI is often used in clinical research to evaluate the prevalence and severity of gingival disease in populations.

Periodontal Medicaments

Periodontal diseases often require adjunctive therapies to traditional mechanical treatments such as scaling and root planing. Various medicaments have been developed to enhance the healing process and control infection in periodontal tissues. This lecture will discuss several periodontal medicaments, their compositions, and their clinical applications.

1. Elyzol

• Composition:
  • Elyzol is an oil-based gel containing 25% metronidazole. It is formulated with glyceryl mono-oleate and sesame oil.
• Clinical Use:
  • Elyzol has been found to be equivalent to scaling and root planing in terms of effectiveness for treating periodontal disease.
  • However, no adjunctive effects beyond those achieved with mechanical debridement have been demonstrated.

2. Actisite

• Composition:

  • Actisite consists of tetracycline-containing fibers.
  • Each fiber has a diameter of 0.5 mm and contains 12.7 mg of tetracycline per 9 inches of fiber.

• Clinical Use:

  • The fibers are placed directly into periodontal pockets, where they release tetracycline over time, helping to reduce bacterial load and promote healing.

3. Arestin

• Composition:

  • Arestin contains minocycline, which is delivered as a biodegradable powder in a syringe.

• Clinical Use:

  • Arestin is indicated for the treatment of periodontal disease and is applied directly into periodontal pockets, where it provides localized antibiotic therapy.

4. Atridox

• Composition:

  • Atridox contains 10% doxycycline in a syringeable gel system that is biodegradable.

• Clinical Use:

  • The gel is injected into periodontal pockets, where it solidifies and releases doxycycline over time, aiding in the management of periodontal disease.

5. Dentamycin and Periocline

• Composition:

  • Both Dentamycin and Periocline contain 2% minocycline hydrochloride.

• Clinical Use:

  • These products are used similarly to other local delivery systems, providing localized antibiotic therapy to reduce bacterial infection in periodontal pockets.

6. Periochip

• Composition:

  • Periochip is a biodegradable chip that contains chlorhexidine.

• Clinical Use:

  • The chip is placed in the gingival crevice, where it releases chlorhexidine over time, providing antimicrobial action and helping to control periodontal disease.

Platelet-Derived Growth Factor (PDGF)

Platelet-Derived Growth Factor (PDGF) is a crucial glycoprotein involved in various biological processes, particularly in wound healing and tissue repair. Understanding its role and mechanisms can provide insights into its applications in regenerative medicine and periodontal therapy.

Overview of PDGF

1. Definition:

   • PDGF is a glycoprotein that plays a significant role in cell growth, proliferation, and differentiation.

2. Source:

   • PDGF is carried in the alpha granules of platelets and is released during the process of blood clotting.

3. Discovery:

   • It was one of the first growth factors to be described in scientific literature.
   • Originally isolated from platelets, PDGF was found to exhibit mitogenic activity specifically in smooth muscle cells.

Functions of PDGF

1. Mitogenic Activity:

   • PDGF stimulates the proliferation of various cell types, including:
     • Smooth muscle cells
     • Fibroblasts
     • Endothelial cells
   • This mitogenic activity is essential for tissue repair and regeneration.

2. Role in Wound Healing:

   • PDGF is released at the site of injury and plays a critical role in:
     • Promoting cell migration to the wound site.
     • Stimulating the formation of new blood vessels (angiogenesis).
     • Enhancing the synthesis of extracellular matrix components, which are vital for tissue structure and integrity.

3. Involvement in Periodontal Healing:

   • In periodontal therapy, PDGF can be utilized to enhance healing in periodontal defects and promote regeneration of periodontal tissues.
   • It has been studied for its potential in guided tissue regeneration (GTR) and in the treatment of periodontal disease.

Clinical Applications

1. Regenerative Medicine:

   • PDGF is being explored in various regenerative medicine applications, including:
     • Bone regeneration
     • Soft tissue healing
     • Treatment of chronic wounds

2. Periodontal Therapy:

   • PDGF has been incorporated into certain periodontal treatment modalities to enhance healing and regeneration of periodontal tissues.
   • It can be used in conjunction with graft materials to improve outcomes in periodontal surgery.

Bone grafting is a critical procedure in periodontal and dental surgery, aimed at restoring lost bone and supporting the regeneration of periodontal tissues. Various materials can be used for bone grafting, each with unique properties and applications.

A. Osseous Coagulum

• Composition: Osseous coagulum is a mixture of bone dust and blood. It is created using small particles ground from cortical bone.
• Sources: Bone dust can be obtained from various anatomical sites, including:
  • Lingual ridge of the mandible
  • Exostoses
  • Edentulous ridges
  • Bone distal to terminal teeth
• Application: This material is used in periodontal surgery to promote healing and regeneration of bone in areas affected by periodontal disease.

B. Bioactive Glass

• Composition: Bioactive glass consists of sodium and calcium salts, phosphates, and silicon dioxide.
• Function: It promotes bone regeneration by forming a bond with surrounding bone and stimulating cellular activity.

C. HTR Polymer

• Composition: HTR Polymer is a non-resorbable, microporous, biocompatible composite made from polymethyl methacrylate (PMMA) and polyhydroxymethacrylate.
• Application: This material is used in various dental and periodontal applications due to its biocompatibility and structural properties.

D. Other Bone Graft Materials

• Sclera: Used as a graft material due to its collagen content and biocompatibility.
• Cartilage: Can be used in certain grafting procedures, particularly in reconstructive surgery.
• Plaster of Paris: Occasionally used in bone grafting, though less common due to its non-biological nature.
• Calcium Phosphate Biomaterials: These materials are osteoconductive and promote bone healing.
• Coral-Derived Materials: Natural coral can be processed to create a scaffold for bone regeneration.

Dental Plaque

Dental plaque is a biofilm that forms on the surfaces of teeth and is composed of a diverse community of microorganisms. The development of dental plaque occurs in stages, beginning with primary colonizers and progressing to secondary colonization and plaque maturation.

Primary Colonizers

• Timeframe:
  • Acquired within a few hours after tooth cleaning or exposure.
• Characteristics:
  • Predominantly gram-positive facultative microbes.
• Key Species:
  • Actinomyces viscosus
  • Streptococcus sanguis
• Adhesion Mechanism:
  • Primary colonizers adhere to the tooth surface through specific adhesins.
  • For example, A. viscosus possesses fimbriae that bind to proline-rich proteins in the dental pellicle, facilitating initial attachment.

Secondary Colonization and Plaque Maturation

• Microbial Composition:
  • As plaque matures, it becomes predominantly populated by gram-negative anaerobic microorganisms.
• Key Species:
  • Prevotella intermedia
  • Prevotella loescheii
  • Capnocytophaga spp.
  • Fusobacterium nucleatum
  • Porphyromonas gingivalis
• Coaggregation:
  • Coaggregation refers to the ability of different species and genera of plaque microorganisms to adhere to one another.
  • This process occurs primarily through highly specific stereochemical interactions of protein and carbohydrate molecules on cell surfaces, along with hydrophobic, electrostatic, and van der Waals forces.

Plaque Hypotheses

1. Specific Plaque Hypothesis:

   • This hypothesis posits that only certain types of plaque are pathogenic.
   • The pathogenicity of plaque depends on the presence or increase of specific microorganisms.
   • It predicts that plaque harboring specific bacterial pathogens leads to periodontal disease due to the production of substances that mediate the destruction of host tissues.

2. Nonspecific Plaque Hypothesis:

   • This hypothesis maintains that periodontal disease results from the overall activity of the entire plaque microflora.
   • It suggests that the elaboration of noxious products by the entire microbial community contributes to periodontal disease, rather than specific pathogens alone.